Biomedical Research Foundation of Northwest Louisiana
Overview
Biomedical Research Foundation of Northwest Louisiana is a nonprofit economic development organization that invests in and supports high-growth initiatives to diversify the region's economy, with a focus on life sciences and technology.
Investments
| Company | Date | Stage | Lead |
|---|---|---|---|
| Starget Pharma | Feb 2026 | Series A | Co-investor |
| Prime Unicorn Index | - | Series C | Co-investor |
Sector & Stage Mix
Industry, funding stage, and valuation band breakdowns.
FAQ
Where is Biomedical Research Foundation of Northwest Louisiana based?
Biomedical Research Foundation of Northwest Louisiana is headquartered in Shreveport, Louisiana, United States.
When was Biomedical Research Foundation of Northwest Louisiana founded?
Biomedical Research Foundation of Northwest Louisiana was founded in 1986.
How many portfolio companies does Biomedical Research Foundation of Northwest Louisiana have?
Biomedical Research Foundation of Northwest Louisiana has 2 portfolio companies in Caplight's dataset.
What are some companies in Biomedical Research Foundation of Northwest Louisiana's portfolio?
Portfolio companies visible on Caplight include Starget Pharma, Prime Unicorn Index.
What was Biomedical Research Foundation of Northwest Louisiana's most recent investment shown here?
Biomedical Research Foundation of Northwest Louisiana's most recent investment in this portfolio sample was in Starget Pharma in 2026.
What sectors does Biomedical Research Foundation of Northwest Louisiana focus on?
Biomedical Research Foundation of Northwest Louisiana focuses on Healthcare & Life Sciences, FinTech, Enterprise Software, Frontier & Industrial Tech.
What company stages does Biomedical Research Foundation of Northwest Louisiana focus on?
Biomedical Research Foundation of Northwest Louisiana typically invests at the Early stage.
What is Biomedical Research Foundation of Northwest Louisiana's AUM?
Biomedical Research Foundation of Northwest Louisiana's assets under management are estimated at over $14.0M.